Vectura's GSK royalties agreements firing on all cylinders

Alexander Bueso Sharecast | 16 Feb, 2017 07:27 | | |

vectura fox
  • 120.70
  • -0.49%-0.60
  • Max: 122.77
  • Min: 120.70
  • Volume: 1,633,501
  • MM 200 : n/a
17:18 23/05/17
  • 3,587.92
  • -0.37%-13.23
  • Max: 3,611.18
  • Min: 3,586.97
  • Volume: 0
  • MM 200 : n/a
17:19 23/05/17
  • 19,920.12
  • 0.04%7.57
  • Max: 19,984.66
  • Min: 19,898.88
  • Volume: 0
  • MM 200 : n/a
17:30 23/05/17
  • 14,397.63
  • -0.75%-108.12
  • Max: 14,558.98
  • Min: 14,390.77
  • Volume: 0
  • MM 200 : n/a
17:30 23/05/17
  • 4,155.20
  • -0.12%-4.80
  • Max: 4,174.35
  • Min: 4,155.20
  • Volume: 0
  • MM 200 : n/a
17:30 23/05/17
  • 4,098.45
  • -0.11%-4.44
  • Max: 4,116.79
  • Min: 4,098.45
  • Volume: 0
  • MM 200 : n/a
17:25 23/05/17
  • 4,618.48
  • -0.49%-22.79
  • Max: 4,656.63
  • Min: 4,618.45
  • Volume: 0
  • MM 200 : n/a
17:19 23/05/17

Vectura Group hit its royalty cap on sales of GlaxoSmithKline´s Ellipta range of products in 2016, one year ahead of forecasts.

The cap was equivalent to £9.0m.

The inhaled airways disease-focused business was also set to record £5.4m of 2016 revenues under a separate single digit percentage royalty agreement with GSK on its Ellipta products.

That latter royalties agreement was a legacy arrangement from its merger with Skyepharma.

Vectura would also receive £7.3m of royalties under a separate royalties agreement which GSK decided not to extend in July 2016 and which had also been running ahead of expectations.

James Ward-Lilley, Chief Executive Officer, commented: "We are pleased to see continued momentum in Vectura's recurring revenues driven by the strong performance of our partnered marketed respiratory products. The merger with Skyepharma has added to the Group's growing revenue streams and combined with anticipated pipeline and partnered programme developments, Vectura is well positioned to capture a growing share of the evolving respiratory market."

More news

17:45 FX round-up: Sterling lower on the crosses as UK data weighs

Sterling ended Tuesday lower on most key pairs in a UK market sombre all day after the deadly Manchester suicide bomb attack last night.

17:43 Europe close: Stocks end higher as euro slips

European stocks ended the day on a high note on the heels of a slate of positive economic data out of the single currency bloc.

17:34 London close: FTSE 100 limps to mildly lower close after Manchester terror attack

London stocks limped to a mildly lower close as a sombre UK came to terms with the deadly suicide bomb attack in Manchester last night.

17:12 Wednesday preview: Retail display as Marks, Dixons, Kingfisher all report

Wednesday will see three big UK retail groups reports results: Marks & Spencer, Dixons Carphone and B&Q owner Kingfisher; while the focus Stateside will be on GDP and meeting minutes from the Federal Reserve.

16:12 Strong US services growth balances softer industrials, PMI surveys show

US services activity grew faster than expected in May, though manufacturing output slowed on the previous month, according to a purchasing managers' index survey published on Tuesday.

15:11 More patents and shelf space for Ventura Life breath care brand

International consumer self-care group Venture Life announced on Tuesday that it had been granted patents in Japan, Indonesia, Australia and Mexico for its UltraDEX Sensitive range.

15:06 ThinkSmart nabs Gerald Grimes from Hitachi Capital

Retail point-of-sale lease finance provider ThinkSmart announced the appointment of Gerald Grimes as chief executive officer on Monday.

15:01 Shanta makes good progress at New Luika and Bauhinia Creek

East Africa-focussed gold producer, developer and explorer Shanta Gold announced on Tuesday that first stope ore had been produced from the New Luika Gold Mine underground operation.

14:54 FTSE 100 movers: EasyJet flies higher on RBC upgrade; M&S drops before results

London's FTSE 100 was up 0.2% to 7,508.08 in afternoon trade.

14:31 Suicide bomb attack in Manchester pop concert leaves 22 dead

A suicide bomber killed 22 people, including many children, and injured more than 50 others at the Manchester Arena on Monday night after an Ariana Grande concert.